financetom
Business
financetom
/
Business
/
Netskope, Inc IPOs Tomorrow, Here's What You Need To Know
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Netskope, Inc IPOs Tomorrow, Here's What You Need To Know
Sep 17, 2025 9:02 AM

Netskope, Inc (NASDAQ:NTSK) IPO will take place September, 18 on the NASDAQ exchange under the ticker NTSK.

The company is offering shares at an expected price between $17.00 and $19.00 per share with an insider lock-up period of 180 days ending on March 17, 2026.

See also: Benzinga IPO Calendar

About Netskope, Inc

Netskope One, our unified, cloud-native platform from the ground up to solve the challenge of securing and accelerating the digital interactions of enterprises in this new era. Organizations rely on our Netskope One platform to provide profound contextual intelligence into their data and digital interactions, securing them with precision, without sacrificing the digital experience.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United-operated Boeing 737 rolls off Houston runway, passengers deplaned, says FAA
United-operated Boeing 737 rolls off Houston runway, passengers deplaned, says FAA
Mar 8, 2024
WASHINGTON, March 8 (Reuters) - A Boeing 737 operated by United Airlines rolled onto the grass when exiting the runway at George Bush Intercontinental Airport in Houston early on Friday, the Federal Aviation Administration said. The passengers left the plane and were bused to the terminal, the FAA said in a brief statement which did not mention any injuries. ...
Market Chatter: Novo Nordisk Intends to Offer Amycretin Obesity Drug This Decade
Market Chatter: Novo Nordisk Intends to Offer Amycretin Obesity Drug This Decade
Mar 8, 2024
10:17 AM EST, 03/08/2024 (MT Newswires) -- Novo Nordisk ( NVO ) plans to offer the pill version of its experimental weight loss drug amycretin this decade, Reuters reported Friday, citing Martin Holst Lange, the company's head of development. I never commit to timelines, but I would be very comfortable to say at the very least within this decade, Lange...
Arrowhead Doses First Subjects in Phase 1/2a Study of Myotonic Dystrophy Treatment; Shares Rise
Arrowhead Doses First Subjects in Phase 1/2a Study of Myotonic Dystrophy Treatment; Shares Rise
Mar 8, 2024
10:25 AM EST, 03/08/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Friday it dosed the first subjects in a phase 1/2a study of its experimental ARO-DM1 treatment of type 1 myotonic dystrophy, the most common adult-onset muscular dystrophy. The study will evaluate single and multiple ascending doses of ARO-DM1 in up to 48 patients, the company said. Patients...
Lockheed Martin Insider Sold Shares Worth $1,941,710, According to a Recent SEC Filing
Lockheed Martin Insider Sold Shares Worth $1,941,710, According to a Recent SEC Filing
Mar 8, 2024
10:16 AM EST, 03/08/2024 (MT Newswires) -- Stephanie C. Hill, Pres. Rotary & Mission Systems, on March 06, 2024, sold 4,499 shares in Lockheed Martin ( LMT ) for $1,941,710. Following the Form 4 filing with the SEC, Hill has control over a total of 16,542 shares of the company, with 12,604 shares held directly and 3,938 shares controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved